Patents by Inventor Alan STOKES

Alan STOKES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYSSAVIRUS ANTIGEN CONSTRUCTS
    Publication number: 20220241398
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Application
    Filed: February 2, 2022
    Publication date: August 4, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: KATHRYN HASHEY, PADMA MALYALA, MARCELO SAMSA, OLGA SLACK, DONG YU, ALAN STOKES, RASHMI JALAH
  • Lyssavirus antigen constructs
    Patent number: 11278613
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: March 22, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kathryn Hashey, Padma Malyala, Marcelo Samsa, Olga Slack, Dong Yu, Alan Stokes, Rashmi Jalah
  • LYSSAVIRUS ANTIGEN CONSTRUCTS
    Publication number: 20200222526
    Abstract: Nucleic acid based vaccine constructs encoding Lyssaviral antigens are useful in preventing and treating diseases. Self-amplifying RNA molecules encoding Lyssaviral antigens provide potent and long-lasting immunity.
    Type: Application
    Filed: July 16, 2018
    Publication date: July 16, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kathryn HASHEY, Padma MALYALA, Marcelo SAMSA, Olga SLACK, Dong YU, Alan STOKES, Rashmi JALAH